IMO Health

IMO Health IMO Health is a clinical data intelligence business improving how data is used across the healthcare landscape. IMO Health. Transforming data.

Transforming healthcare. IMO Health is a clinical data intelligence business at the heart of a digital revolution in healthcare. Combining rich, highly nuanced medical terminology, extensive domain knowledge, and artificial intelligence (AI), we expertly structure and operationalize clinical data to generate sharper insights and inform more intelligent decision-making. Deeply embedded in the provider world, we developed a comprehensive intelligence layer that captures and encodes patient encounters with unmatched completeness and precision. Now, by weaving ethical and accountable AI into this robust content, we are improving how data is used across the healthcare landscape with powerful new applications in health tech, drug discovery, population health, and payer processes.

The output looks convincing. Then someone asks, “What was this built on?” 📞In healthcare, a familiar term can hide missi...
10/30/2026

The output looks convincing. Then someone asks, “What was this built on?” 📞

In healthcare, a familiar term can hide missing specificity, a negated condition, or a historical diagnosis mistaken for a current one. An AI model’s fluency doesn’t make those distinctions disappear.

Before trusting the answer, check the clinical meaning behind it: https://bit.ly/42Pwt25

10/29/2026

Prior authorization is only one part of getting paid.

Even when approval is in place, gaps in documentation, medical necessity, coding, or downstream workflows can still put reimbursement at risk.

Join IMO Health experts Holly Ridge, BSN, RN, CPC, CPMA, and Jessica Mason, RHIA, on Thursday, November 5 at 12 PM CT for a closer look at the myths that can create false confidence in the prior authorization process.

They’ll break down where approval and payment can diverge — and what organizations can do to strengthen workflows before those gaps turn into denials.

Register now: https://bit.ly/4i6RSuG

10/27/2026

Medical affairs teams can measure reach.

But what happens after the engagement?

Congress attendance, MSL interactions, publication engagement, and CME participation can show whether scientific exchange reached its intended audience. The harder question is whether the clinical conversation changed afterward.

Changes in terminology activity can add another layer of insight – helping teams investigate which clinical concepts are gaining traction, where activity is shifting, and where additional education may be needed.

Our latest blog explores how medical affairs teams can look beyond engagement metrics to better understand what happens next. https://bit.ly/47DL17j

New system. Fresh dashboard. Same ambiguity reaching up from underneath.Moving clinical data doesn’t resolve what it mea...
10/27/2026

New system. Fresh dashboard. Same ambiguity reaching up from underneath.

Moving clinical data doesn’t resolve what it means. When terms are inconsistent, or detail gets lost, yesterday’s uncertainty can become tomorrow’s cleanup.

This Halloween, let’s retire the workaround – not the clinical context: https://bit.ly/42Pwt25

Apparently, “we’ll fix it downstream” is how the sequel starts. 🧟A missing clinical detail doesn’t always stay put. It c...
10/22/2026

Apparently, “we’ll fix it downstream” is how the sequel starts. 🧟

A missing clinical detail doesn’t always stay put. It can follow the data into coding, analytics, and AI – giving every team a different version of the same headache.

The better plot twist? Preserve the clinical meaning before the problem gets a bigger cast: https://bit.ly/4eudsIT

10/22/2026

Clinical AI works.

The next question is whether the economics work at scale.

As AI moves from pilots into everyday workflows, token costs are only part of the equation. Model choice, context length, number of calls, architecture, and how much reasoning gets pushed onto the model can all shape the cost of completing a clinical task.

That means the metric that matters may not be cost per token.

It’s cost per trusted completed task.

In our latest blog, IMO Health Chief Product Officer Ivana Naeymi-Rad explores how clinical context, model choice, and architecture can help healthcare technology and life sciences teams build AI that is not only effective – but economically sustainable. https://bit.ly/47BLAOP

Healthcare organizations can’t simply work their way out of the denial problem.Prior authorization gaps, medical necessi...
10/21/2026

Healthcare organizations can’t simply work their way out of the denial problem.

Prior authorization gaps, medical necessity issues, coding errors, eligibility problems, missing documentation, and other common denial drivers can create costly rework long after the underlying issue first occurred.

The bigger opportunity is prevention.

Our latest blog breaks down 10 common types of healthcare claim denials RCM leaders should know — and where organizations can address root causes earlier in the clinical and revenue cycle workflow.

Read the blog to see where preventable denials begin. https://bit.ly/4BeQjnn

10/20/2026

Prior authorization approved.

So why was the claim still denied?

Authorization and medical necessity are not the same thing — and when documentation, coding, and workflow gaps get in the way, an approved authorization can still end in lost reimbursement.

Join IMO Health experts Holly Ridge, BSN, RN, CPC, CPMA, and Jessica Mason, RHIA, on Thursday, November 5 at 12 PM CT for a practical discussion on where the disconnect happens and how organizations can reduce preventable denials.

You’ll learn how to strengthen documentation, improve coding alignment, and identify workflow blind spots before they put reimbursement at risk.

Register now.

10/16/2026

More specific does not always mean more accurate.

For clinical AI, the challenge is not just identifying the most detailed diagnosis available. It is knowing how far the evidence actually supports going.

In this two-minute demo, see how an AI agent uses IMO Health’s Knowledge Graph to evaluate a patient with chronic kidney disease, explore more specific clinical concepts, and determine the appropriate level of diagnostic specificity based on the documentation provided.

Just as importantly, the agent knows when to stop.

See how a grounded clinical Knowledge Graph can help AI reason with greater precision without going beyond the evidence. https://bit.ly/3VFdw1I

10/15/2026

The denial may show up downstream.

But the problem often starts much earlier.

An ambiguous diagnosis, outdated procedure code, missing mapping, or inconsistent clinical term can travel through documentation, prior authorization, coding, and claims before anyone realizes something went wrong.

That is why clinical data governance is becoming a revenue protection strategy.

Our latest asset explores how clinical data drifts over time, four steps organizations can take to govern it more effectively, and how one health system reduced annual write-offs by $6.4M after addressing mapping gaps.

Read more to see why preventing revenue loss starts upstream. https://bit.ly/4zqMz00

Address

9600 West Bryn Mawr Avenue, Suite 100
Rosemont, IL
60018

Alerts

Be the first to know and let us send you an email when IMO Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to IMO Health:

Shortcuts

Share

Nearby computer & electronics services


Other Information Technology Companies in Rosemont

Show All